News & Investors

Want to stay updated? Subscribe to our newsletters. For free.

Have questions? Our live support would be happy to help you.

Author: mark

DGAP-DD: Epigenomics AG deutsch

Meldung und öffentliche Bekanntgabe der Geschäfte von Personen, die Führungsaufgaben wahrnehmen, sowie in enger Beziehung zu ihnen stehenden Personen 23.05.2019 / 15:09 Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. 1. Angaben zu den Personen, die Führungsaufgaben wahrnehmen, sowie zu den in enger Beziehung zu ihnen stehenden Personen a) Name Titel: Vorname: […]

Read more

Epigenomics AG: New Report Shows CRC Screening Rates Increased When a Medically Underserved Population is Offered Epi proColon(R) Blood Test

DGAP-News: Epigenomics AG / Key word(s): Study results 20.05.2019 / 08:41 The issuer is solely responsible for the content of this announcement. New Report Shows CRC Screening Rates Increased When a Medically Underserved Population is Offered Epi proColon(R) Blood Test Data Presented at DDW 2019 Show 93.6% Acceptance Rate Among Patients Unwilling or Unable to […]

Read more

Epigenomics (ECX-DE): Key catalysts to fuel growth throughout 2019

goetzpartners securities Limited 16-May-2019 / 14:16 GMT/BST Free to access research and investor meetings in a post-MiFID2 world. This research report is intended for use only by persons who qualify as professional investors or eligible counterparties (institutional investors) in the applicable jurisdiction, and not by any private individuals or other persons who qualify as retail […]

Read more

DGAP-DD: Epigenomics AG deutsch

Meldung und öffentliche Bekanntgabe der Geschäfte von Personen, die Führungsaufgaben wahrnehmen, sowie in enger Beziehung zu ihnen stehenden Personen 09.05.2019 / 18:44 Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. 1. Angaben zu den Personen, die Führungsaufgaben wahrnehmen, sowie zu den in enger Beziehung zu ihnen stehenden Personen a) Name Titel: Vorname: […]

Read more

Epigenomics AG: Epi proColon(R) Receives the 2019 Excellence in Molecular Diagnostics Award

DGAP-News: Epigenomics AG / Key word(s): Miscellaneous 09.05.2019 / 11:29 The issuer is solely responsible for the content of this announcement. Epi proColon Receives the 2019 Excellence in Molecular Diagnostics Award Corporate LiveWire acknowledges the importance of a patient-accepted CRC detection method to effectively diagnose colorectal cancer.  Berlin (Germany) and San Diego, CA (U.S.A.), May […]

Read more

Epigenomics AG Reports 2019 First Quarter Financial Results

DGAP-News: Epigenomics AG / Key word(s): Quarterly / Interim Statement 08.05.2019 / 08:00 The issuer is solely responsible for the content of this announcement. Epigenomics AG Reports 2019 First Quarter Financial Results  Berlin (Germany) und San Diego, CA (U.S.A.), May 8, 2019 – Epigenomics AG (FSE: ECX, OTCQX: EPGNY; the “Company”) today announced the financial […]

Read more